Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

3077415 Title: REDUCTION DES SYMPTOMES DES MALADIES INFLAMMATOIRES PAR DE PEPTIDE COURTS QUI SIGNALLENT VIA CD28

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
148307341
WO application number:
IL2014051067
Type:
European patent granted for BE
Status:
Lapsed
Publication number:
3077415
WO publication number:
WO2015083173
1rst applicant's nationality:
Translation language:
EPO publication language:
English
SPC number:

Dates

Filing date:
07/12/2014
Grant date:
12/02/2020
EP publication date:
12/10/2016
WO publication date:
11/06/2015
Claims translation received date:
Translation received date (EP publication B1):
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
12/02/2020
EP B1 publication date:
12/02/2020
EP B2 publication date:
EP B3 publication date:
Lapsed date:
31/12/2020
Expiration date (if granted and all annual fees paid):
07/12/2034

Applicant

1

Name:
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.
Legal Form:
From:
12/02/2020
Address:
Hi Tech Park Edmond Safra Campus Givat-Ram, 9139002 Jerusalem, Israel (IL)
To:

2

Name:
Atox Bio Ltd.
Legal Form:
From:
12/02/2020
Address:
3 Golda Meir Street Weizmann Science Park, 74036 Ness Ziona, Israel (IL)
To:

Inventor

1

Name:
KAEMPFER, Raymond
Legal Form:
Address:
9370719 Jerusalem, Israel (IL)

2

Name:
SHIRVAN, Anat
Legal Form:
Address:
4464500 Kfar-Saba, Israel (IL)

3

Name:
ARAD, Gila
Legal Form:
Address:
9079554 Mevasseret Zion, Israel (IL)

Priority

1

Priority patent number:
201461924869 P
Priority date:
08/01/2014
Priority country:
United States (US)

2

Priority patent number:
201361912631 P
Priority date:
06/12/2013
Priority country:
United States (US)

Classification

IPC or IDT classification:
A61K 38/17; C07K 14/705;

Publication

Bulletin

1

Bulletin heading:
EP2
Journal edition number:
2020/05
Publication date:
02/04/2020
Description:
Contains data concerning European patents granted and published (B1 publication) for Belgium and for which no translation needed to be filed

2

Bulletin heading:
VRV
Journal edition number:
2021/15
Publication date:
03/09/2021
Description:
Contains data concerning lapse, annulment or rejection of patent(s) (applications) and SPC (applications)

European Patent Bulletin

Issue number:
202007
Publication date:
12/02/2020
Description:
Grant (B1)

Annual fee

Annual fee(s) Due Date:
Annual fee number:
Expected payer:
Last annual fee payment date:
Last annual fee paid number:
Payer:
Filing date Document type Publication Type Document Description Number of pages File Type